Previous close | 1.1800 |
Open | 1.2100 |
Bid | 1.1800 x 200 |
Ask | 1.1900 x 100 |
Day's range | 1.1600 - 1.2100 |
52-week range | 0.9100 - 28.5000 |
Volume | |
Avg. volume | 1,849,852 |
Market cap | 28.647M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.2100 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.00 |
Meyreuil, France, May 01, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) (“SEALSQ” or “Company”), a leader in semiconductor, PKI, and Post-Quantum technology development, is pleased to announce the rebranding of its semiconductor manufacturing business from WISeKey Semiconductors S.A.S to SEALSQ France S.A.S (“SEALSQ France”). This strategic change is aimed at accelerating the development of state-of-the-art post-quantum semiconductor technologies in Meyreuil, located in the Aix-en-Provence
Geneva, Switzerland, April 30, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced that it has initiated the production phase of engineering samples of its new QS7001™ quantum resistant hardware platform. Concurrently, the Company is leveraging on this design to develop custom ASICs for several large players in the market. As a
Geneva, Switzerland, April 24, 2024 (GLOBE NEWSWIRE) -- SEALSQ’s semiconductor technology provides secure, reliable, and intuitive functionality for a wide array of medical applications. SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced its technology strategy and solutions for IoMT security for medical and healthcare sectors. SEALSQ is leading the ch